CD8A and head and neck squamous cell carcinoma: Additionally, the expression of other immune regulatory receptors (i.e., PD-1, ICOS, and LAG-3), the abundance of several types of T cells (i.e., CD3+, CD8+, and Treg) and their prognostic impacts on resected HNSCC outcomes were evaluated.